Peripheral neuropathy in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 7, Issue 1, 2010, Pages 11-16

  Öncel, Çaatay ^a   Baser, Sevin ^a   Çam, Mustafa ^a   Akda, Beyza ^a   Taspinar, Betul ^a   Evyapan, Fatma ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

COPD; Peripheral neuropathy; Proinflammatory cytokines

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ABDUCTOR MUSCLE; ACTION POTENTIAL; ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DYNAMOMETRY; EXTENSOR MUSCLE; FEMALE; FLEXOR MUSCLE; FORCED EXPIRATORY VOLUME; HUMAN; LATENT PERIOD; MALE; MOTOR NERVE CONDUCTION; MUSCLE STRENGTH; PERIPHERAL NEUROPATHY; PERONEAL NEUROPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSORY NERVE CONDUCTION; SKELETAL MUSCLE; SURAL NERVE; TIBIAL NERVE; ULNAR NERVE;

ACTION POTENTIALS; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 77949394122     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412550903499480     Document Type: Article

References (31)

1. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy. Respirology 2006; 11(6):681-686.
2. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26(4):703-719.
3. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59(7):574-580.
4. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP. Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 2001; 86:4139-4146.
5. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998; 32:393-397.
6. Debigaré R, Marquis K, Côté CH, Tremblay RR, Michaud A, LeBlanc P, Maltais F. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124(1):83-89.
7. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003; 58(9):752-756.
8. Ignatowski TA, Covey WC, Knight PR, Severin CM, Nickola TJ, Spengler RN. Brain-derived TNF alpha mediates neuropathic pain. Brain Res 1999; 841(1-2):70-77.
9. Andriambeloson E, Baillet C, Vitte PA, Garotta G, Dreano M, Callizot N. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology 2006; 26(1):32-42.
10. Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ. TNF-alpha expression in painful and non-painful neuropathies. Neurology 2001; 56(10):1371-1377.
11. González-Clemente JM, Mauricio D, Richart C, Broch M, Caixàs A, Megia A, Giménez-Palop O, Simón I, Mart́inez-Riquelme A, Giménez-Pérez G, Vendrell J. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. Clin Endocrinol 2005; 63(5):525-529.
12. Aarli JA. Role of cytokines in neurological disorders. Curr Med Chem 2003; 10(19): 1931-1937.
13. O'Shea SD, Taylor NF, Paratz JD. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil 2007; 88(1):32-36.
14. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther 1996; 76(3):248-259.
15. American Thoracic Society. Standardization of Spirometry, Update. Am J Respir Crit Care Med 1994; 152:1107-1136.
16. Agrawal D, Vohra R, Gupta PP, Sood S. Subclinical peripheral neuropathy in stable middle-aged patients with chronic obstructive pulmonary disease. Singapore Med J 2007; 48(10):887-894.
17. Jarratt JA, Morgan CN, Twomey JA, Abraham R, Sheaff PC, Pilling JB, Payan J, Mitchell JD, Tang O, Arnaud F. Neuropathy in chronic obstructive pulmonary disease: a multicentre electro-physiological and clinical study. Eur Respir J 1992; 5(5):517-524.
18. Kayacan O, Beder S, Deda G, Karnak D. Neurophysiological changes in COPD patients with chronic respiratory insufficiency. Acta Neurol Belg 2001; 101(3):160-165.
19. Ludemann P, Dziewas R, Soros P, Happe S, Frese A. Axonal polyneuropathy in obstructive sleep apnoea. J Neurol Neurosurg Psych 2001; 70(5):685-687.
20. Ozge A, Atiş S, Sevim S. Subclinical peripheral neuropathy associated with chronic obstructive pulmonary disease. Electromyogr Clin Neurophysiol 2001; 41(3):185-191.
21. Mitchell BD, Hawthorne VM, Vinik AI. Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 1990; 13(4):434-437.
22. Uceyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007; 69(1):42-49.
23. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J 2003; 46:76-80.
24. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(3):250-255.
25. Saey D, Côté CH, Mador MJ, Laviolette L, LeBlanc P, Jobin J, Maltais F. Assessment of muscle fatigue during exercise in chronic obstructive pulmonary disease. Muscle Nerve 2006; 34(1):62-71.
26. Janaudis-Ferreira T, Wadell K, Sundelin G, Lindström B. Thigh muscle strength and endurance in patients with COPD compared with healthy controls. Respir Med 2006; 100(8):1451-1457.
27. Franssen FM, Broekhuizen R, Janssen PP, Wouters EF, Schols AM. Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Med Sci Sports Exerc 2005; 37(1):2-9.
28. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(2):629-634.
29. Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2000; 20(6):353-360.
30. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153(3):976-980.
31. Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, Polkey MI, Moxham J. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003; 58(8):665-669.